Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,514 | 103,670 | 49,591 | 1,923 | N/A |
| Marketable Securities | 6,171 | 8,091 | N/A | N/A | N/A |
| Other current assets | 2,195 | 0 | 0 | 0 | 0 |
| TOTAL | $195,880 | $112,650 | $49,914 | $2,169 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 8,475 | 3,014 | 200 | 13 | N/A |
| Investments And Advances | 497 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,171 | 452 | 0 | 0 | 0 |
| TOTAL | $13,143 | $3,466 | $200 | $13 | $N/A |
| Total Assets | $209,023 | $116,116 | $50,114 | $2,182 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,021 | 888 | 193 | 42 | 0 |
| Accrued Expenses | 1,826 | 1,708 | 447 | 1 | N/A |
| TOTAL | $3,327 | $2,596 | $640 | $43 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,782 | 294 | 0 | 1,850 | 0 |
| TOTAL | $2,782 | $294 | $N/A | $1,850 | $N/A |
| Total Liabilities | $6,109 | $2,890 | $640 | $1,893 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,358 | 14,431 | 10,307 | N/A | N/A |
| Retained earnings | -39,047 | -19,959 | -9,070 | -1,150 | N/A |
| Other shareholders' equity | 10 | 2 | 0 | 0 | 0 |
| TOTAL | $202,914 | $113,226 | $49,474 | $289 | $N/A |
| Total Liabilities And Equity | $209,023 | $116,116 | $50,114 | $2,182 | $0 |